The association between changes in proteinuria and the risk of cerebral infarction in the Korean population

Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:439–458. Shin, 2020, Metabolome changes in cerebral ischemia, Cells, 9, 1630, 10.3390/cells9071630 Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization: IHME, University of Washington; 2020. Accessed December 25, 2020. Virani, 2020, Heart disease and stroke statistics-2020 update: a report from the American Heart Association, Circulation, 141, e139, 10.1161/CIR.0000000000000757 GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 2021;20:795–820. Ninomiya, 2009, Proteinuria and stroke: a meta-analysis of cohort studies, Am J Kidney Dis, 53, 417, 10.1053/j.ajkd.2008.08.032 Hillege, 2002, Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population, Circulation, 106, 1777, 10.1161/01.CIR.0000031732.78052.81 Kelly, 2020, Proteinuria as an independent predictor of stroke: systematic review and meta-analysis, Int J Stroke, 15, 29, 10.1177/1747493019895206 Lee, 2010, Impact of microalbuminuria on incident stroke: a meta-analysis, Stroke, 41, 2625, 10.1161/STROKEAHA.110.581215 Zhang, 2015, Proteinuria is an independent risk factor for first incident stroke in adults under treatment for hypertension in China, J Am Heart Assoc, 4, 10.1161/JAHA.115.002639 Lee, 2022, Urine protein levels predict future development of cerebral infarction in Koreans, Yonsei Med J, 63, 66, 10.3349/ymj.2022.63.1.66 Bakris, 2008, Slowing nephropathy progression: focus on proteinuria reduction, Clin J Am Soc Nephrol, 3 Suppl 1, S3, 10.2215/CJN.03250807 Yong, 2016, The influence of body composition on renal function in patients with coronary artery disease and its prognostic significance: a retrospective cohort study, Cardiovasc Diabetol, 15, 106, 10.1186/s12933-016-0420-7 Imai, 2016, Effects of blood pressure on renal and cardiovascular outcomes in Asian patients with type 2 diabetes and overt nephropathy: a post hoc analysis (ORIENT-blood pressure), Nephrol Dial Transplant, 31, 447, 10.1093/ndt/gfv272 Lee, 2017, Cohort profile: the national health insurance service-national sample cohort (NHIS-NSC), South Korea Int J Epidemiol, 46 Nagata M, Ninomiya T, Kiyohara Y, Murakami Y, Irie F, Sairenchi T, et al. Prediction of cardiovascular disease mortality by proteinuria and reduced kidney function: pooled analysis of 39,000 individuals from 7 cohort studies in Japan. Am J Epidemiol. 2013;178:1–11. Pesola, 2015, Dipstick proteinuria as a predictor of all-cause and cardiovascular disease mortality in Bangladesh: a prospective cohort study, Prev Med, 78, 72, 10.1016/j.ypmed.2015.07.009 Schmieder, 2011, Changes in albuminuria predict mortality and morbidity in patients with vascular disease, J Am Soc Nephrol, 22, 1353, 10.1681/ASN.2010091001 Wang, 2018, Proteinuria and risk of stroke in patients with hypertension: the Kailuan cohort study, J Clin Hypertens (Greenwich), 20, 765, 10.1111/jch.13255 Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004;109(23 Suppl 1):III27–III32. Gorelick, 2008, Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier, Stroke, 39, 2396, 10.1161/STROKEAHA.107.505776 Hirano, 1997, Albuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDM patients, Diabetes Res Clin Pract, 36, 11, 10.1016/S0168-8227(97)01384-3 Knöbl, 1993, Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients, Diabetologia, 36, 1045, 10.1007/BF02374497 Arenillas, 2007, The metabolic syndrome and stroke: potential treatment approaches, Stroke, 38, 2196, 10.1161/STROKEAHA.106.480004 Fornoni, 2005, Metabolic syndrome and endothelial dysfunction, Curr Hypertens Rep, 7, 88, 10.1007/s11906-005-0080-6 Savarese, 2014, Reduction of albumin urinary excretion is associated with reduced cardiovascular events in hypertensive and/or diabetic patients. A meta-regression analysis of 32 randomized trials, Int J Cardiol, 172, 403, 10.1016/j.ijcard.2014.01.065 Araki, 2007, Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes, Diabetes, 56, 1727, 10.2337/db06-1646 Petrea, 2009, Gender differences in stroke incidence and poststroke disability in the Framingham heart study, Stroke, 40, 1032, 10.1161/STROKEAHA.108.542894 Reeves, 2008, Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes, Lancet Neurol, 7, 915, 10.1016/S1474-4422(08)70193-5 de Leciñana MA, Egido JA, Fernández C, Martinez-Vila E, Santos S, Morales A, et al. Risk of ischemic stroke and lifetime estrogen exposure. Neurology 2007;68:33–8. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150. Hankey, 2003, Angiotensin-converting enzyme inhibitors for stroke prevention: is there HOPE for PROGRESS After LIFE?, Stroke, 34, 354, 10.1161/01.STR.0000054261.97525.4B Hackam, 2009, Angiotensin receptor blockers should be regarded as first-line drugs for stroke prevention in both primary and secondary prevention settings: yes, Stroke, 40, 3159, 10.1161/STROKEAHA.109.559054